A Study to Evaluate the Effect of KarXT on Urological Safety
- Conditions
- Schizophrenia
- Interventions
- Drug: Xanomeline/trospium chloride
- Registration Number
- NCT07221877
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 60
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description KarXT Xanomeline/trospium chloride -
- Primary Outcome Measures
Name Time Method Change from baseline in voiding dynamics (Qmax) over time Up to 12 months Change from baseline in post-void residual volume (PVR) over time Up to 12 months
- Secondary Outcome Measures
Name Time Method Number of participants with a change from baseline in urinalysis parameters over time Up to 12 months Number of participants with vital sign abnormalities Up to 12 months Number of participants with Adverse Events (AEs) Up to 12 months Change from baseline in IPSS over time Up to 12 months Number of participants with electrocardiogram (ECG) abnormalities Up to 12 months Number of participants with AEs of Special Interest (AESIs) Up to 12 months Number of participants with Serious AEs (SAEs) Up to 12 months Number of participants with suicidal ideation or behavior Up to 12 months
Trial Locations
- Locations (16)
Local Institution - 0017
🇺🇸Little Rock, Arkansas, United States
Local Institution - 0007
🇺🇸Bellflower, California, United States
Local Institution - 0009
🇺🇸Culver City, California, United States
Local Institution - 0006
🇺🇸Los Alamitos, California, United States
Local Institution - 0016
🇺🇸Orange, California, United States
Local Institution - 0003
🇺🇸Miami, Florida, United States
Local Institution - 0008
🇺🇸Miami, Florida, United States
Local Institution - 0004
🇺🇸Stuart, Florida, United States
Local Institution - 0005
🇺🇸Chicago, Illinois, United States
Local Institution - 0010
🇺🇸Chicago, Illinois, United States
Scroll for more (6 remaining)Local Institution - 0017🇺🇸Little Rock, Arkansas, United StatesSite 0017Contact
